A trial to assess a new therapy for artery weakening

评估动脉衰弱新疗法的试验

• 批准号: nhmrc : GNT1022752
• 负责人: Dr Anna Ahimastos
• 金额: $ 110.59万
• 依托单位: James Cook University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/trial-assess-new-artery-weakening/1344301
• 关键词: trial; assess; new; therapy; artery

Approximately 5% of men and 1% of women aged over 60 years develop weakening of the main abdominal artery. Currently the management of artery weakening is focused on surgery with no effective medications available. In this trial we will examine the value of a promising drug therapy. If proved effective this medication could reduce the requirement for surgery by controlling artery weakening at an early stage in its development.

大约5%的男性和1%的60岁以上的女性发展为腹部主动脉弱化。目前，动脉弱化的管理集中在手术上，没有有效的药物可用。在这项试验中，我们将研究一种有前途的药物治疗的价值。如果证明有效，这种药物可以通过在其发展的早期阶段控制动脉弱化来减少手术的需要。